Efficacy and safety profile of intravitreal dexamethasone implant versus antivascular endothelial growth factor treatment in diabetic macular edema: a systematic review and meta-analysis
Abstract To better understand the efficacy of intravitreal dexamethasone implant (Ozurdex) versus antivascular endothelial growth factor (anti-VEGF) treatment in patients with diabetic macular edema (DME). A systematic review and meta-analysis. The study included randomized control trials (RCTs) and...
Main Authors: | Sheng-Chu Chi, Yi-No Kang, Yi-Ming Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-34673-z |
Similar Items
-
Intravitreal dexamethasone implants for diabetic macular edema
by: Alicia Pareja-Ríos, et al.
Published: (2018-01-01) -
Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
by: Claudio Furino, et al.
Published: (2020-10-01) -
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
by: Hakan Koc, et al.
Published: (2023-03-01) -
Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
by: Eugene Yu-Chuan Kang, et al.
Published: (2021-08-01) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
by: Ke-Ke Hu, et al.
Published: (2022-12-01)